降钙素基因相关肽
胰淀素
受体
降钙素受体
降钙素
化学
细胞外
G蛋白偶联受体
肽
生物化学
细胞生物学
内分泌学
生物
神经肽
小岛
胰岛素
作者
Jianjun Cao,Matthew J. Belousoff,Radostin Danev,Arthur Christopoulos,Denise Wootten,Patrick M. Sexton
出处
期刊:Biochemistry
[American Chemical Society]
日期:2024-04-11
卷期号:63 (9): 1089-1096
被引量:2
标识
DOI:10.1021/acs.biochem.4c00114
摘要
Inhibition of calcitonin gene-related peptide (CGRP) or its cognate CGRP receptor (CGRPR) has arisen as a major breakthrough in the treatment of migraine. However, a second CGRP-responsive receptor exists, the amylin (Amy) 1 receptor (AMY1R), yet its involvement in the pathology of migraine is poorly understood. AMY1R and CGRPR are heterodimers consisting of receptor activity-modifying protein 1 (RAMP1) with the calcitonin receptor (CTR) and the calcitonin receptor-like receptor (CLR), respectively. Here, we present the structure of AMY1R in complex with CGRP and Gs protein and compare it with the reported structures of the AMY1R complex with rat amylin (rAmy) and the CGRPR in complex with CGRP. Despite similar protein backbones observed within the receptors and the N- and C-termini of the two peptides bound to the AMY1R complexes, they have distinct organization in the peptide midregions (the bypass motif) that is correlated with differences in the dynamics of the respective receptor extracellular domains. Moreover, divergent conformations of extracellular loop (ECL) 3, intracellular loop (ICL) 2, and ICL3 within the CTR and CLR protomers are evident when comparing the CGRP bound to the CGRPR and AMY1R, which influences the binding mode of CGRP. However, the conserved interactions made by the C-terminus of CGRP to the CGRPR and AMY1R are likely to account for cross-reactivity of nonpeptide CGRPR antagonists observed at AMY1R, which also extends to other clinically used CGRPR blockers, including antibodies.
科研通智能强力驱动
Strongly Powered by AbleSci AI